The Inhibitory Effects of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide on Osteoclast Formation Are Associated with Upregulation of Osteoprotegerin and Downregulation of RANKL and RANK

By Mukohyama H.   Ransjö M.   Taniguchi H.   Ohyama T.   Lerner U.H.  

Biochemical and Biophysical Research Communications, Vol. 271, Iss. 1, 2000-04 ,pp. : 158-163

Elsevier

Access to resources Recommend Favorite

Pituitary Adenylate Cyclase-Activating Polypeptide Prevents Cytokine-Induced Cytotoxicity via Inhibition of Inducible Nitric Oxide Synthase Expression in βTC Cells

By Sekiya K.   Nagasaki H.   Ozaki N.   Suzuki A.   Miura Y.   Oiso Y.  

Biochemical and Biophysical Research Communications, Vol. 278, Iss. 1, 2000-11 ,pp. : 211-216

Elsevier

Access to resources Recommend Favorite

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia

By Delgado M.  

Biochemical and Biophysical Research Communications, Vol. 293, Iss. 2, 2002-05 ,pp. : 771-776

Elsevier

Access to resources Recommend Favorite

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP–NF-κB interaction in activated microglia

By Delgado M.  

Biochemical and Biophysical Research Communications, Vol. 297, Iss. 5, 2002-10 ,pp. : 1181-1185

Elsevier

Access to resources Recommend Favorite

Progesterone Receptor Activation Mediates LH-Induced Type-I Pituitary Adenylate Cyclase Activating Polypeptide Receptor (PAC₁) Gene Expression in Rat Granulosa Cells

By Ko C.   Park-Sarge O-K.  

Biochemical and Biophysical Research Communications, Vol. 277, Iss. 1, 2000-10 ,pp. : 270-279

Elsevier

Access to resources Recommend Favorite